
The Karnataka government flagged major price disparities between institutional landing costs and Maximum Retail Prices for essential medicines and cancer drugs supplied to hospitals.
Investigations by the Food Safety and Drug Administration revealed markups ranging from 10 times to over 52 times the actual procurement cost across 253 drugs.
Karnataka wrote to the Union Ministry of Health and Family Welfare seeking mandatory cost-to-MRP transparency on patient bills and price controls.